Evidence map›Paper›PMID 35502272›Full record

ReviewWorld journal of nuclear medicine2022

Comparison of

Habibollah Dadgar, Nasim Norouzbeigi, Narges Jokar, Jafar Zareizadeh, Ali Gholamrezanezhad, Hojjat Ahmadzadehfar, Moloud Abbaszadeh, Majid Assadi

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of nuclear medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Cartilage-SpecificBiomedicines · 2025
    Article
  2. Radiopharmaceuticals and their applications in medicine.Signal transduction and targeted therapy · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. The Role of PET/CT in Breast Cancer.Diagnostics (Basel, Switzerland) · 2023
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Habibollah DadgarCancer Research Center, Imam Reza International University, Razavi Hospital, Mashhad, Iran.
Nasim NorouzbeigiCancer Research Center, Imam Reza International University, Razavi Hospital, Mashhad, Iran.
Narges JokarDepartment of Molecular Imaging and Radionuclide Therapy (MIRT), The Persian Gulf Nuclear Medicine Research Center, School of Medicine, Bushehr University of Medical Sciences, Bushehr Medical University Hospital, Bushehr, Iran.
Jafar ZareizadehDepartment of Emergency Medicine, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Ali GholamrezanezhadDepartment of Diagnostic Radiology, Keck School of Medicine, University of Southern California (USC), Los Angeles, California, United States.
Hojjat AhmadzadehfarDepartment of Nuclear Medicine, Klinikum Westfalen, Dortmund, Germany.
Moloud AbbaszadehDepartment of Internal Medicine, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Majid AssadiDepartment of Molecular Imaging and Radionuclide Therapy (MIRT), The Persian Gulf Nuclear Medicine Research Center, School of Medicine, Bushehr University of Medical Sciences, Bushehr Medical University Hospital, Bushehr, Iran.
Bushehr University of Medical Sciences · IRImam Reza International University · IRKlinikum Westfalen (Germany) · DEUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone is a common metastasis site in several malignancies, most importantly prostate and breast cancers. Given the significance of the early and accurate diagnosis of bone metastases for preliminary staging, treatment planning and monitoring, restaging, and survival prediction in patients with malignancy, it is critical to compare and contrast the strengths and weaknesses of imaging modalities. Although technetium-99m-labeled diphosphonates [

Indexed as

99m Tc-MDPfluorodeoxyglucose (FDG)skeletal metastasessodium fluoride (NaF)

Identifiers

PMID35502272
PMCPMC9056122
OpenAlexW4225252448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.